Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 172

1.

Cerebrospinal fluid penetration of high-dose daptomycin in suspected Staphylococcus aureus meningitis.

Riser MS, Bland CM, Rudisill CN, Bookstaver PB.

Ann Pharmacother. 2010 Nov;44(11):1832-5. doi: 10.1345/aph.1P307. Epub 2010 Oct 19.

PMID:
20959502
2.

Daptomycin is more efficacious than vancomycin against a methicillin-susceptible Staphylococcus aureus in experimental meningitis.

Gerber P, Stucki A, Acosta F, Cottagnoud M, Cottagnoud P.

J Antimicrob Chemother. 2006 Apr;57(4):720-3. Epub 2006 Feb 3.

PMID:
16459345
3.

Persistent methicillin-sensitive Staphylococcus aureus (MSSA) bacteremia due to a linezolid "tolerant" strain.

Cunha BA, Nausheen S, Schoch P.

Heart Lung. 2010 Mar-Apr;39(2):173-5. doi: 10.1016/j.hrtlng.2009.06.005. Epub 2009 Sep 3.

PMID:
20207279
4.

Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin.

Lee DH, Palermo B, Chowdhury M.

Clin Infect Dis. 2008 Aug 15;47(4):588-90. doi: 10.1086/590257. No abstract available.

PMID:
18636964
5.

Daptomycin failure in a neutropenic leukemia patient with Staphylococcus aureus meningitis.

Wahby KA, Alangaden GJ.

Leuk Lymphoma. 2012 Aug;53(8):1610-2. doi: 10.3109/10428194.2012.661051. Epub 2012 Apr 18. No abstract available.

PMID:
22390617
6.

Successful treatment of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus bacteremia with the addition of rifampin to daptomycin.

Ahmad NM, Rojtman AD.

Ann Pharmacother. 2010 May;44(5):918-21. doi: 10.1345/aph.1M665. Epub 2010 Mar 30.

PMID:
20354160
7.

Combination therapy with daptomycin, linezolid, and rifampin as treatment option for MRSA meningitis and bacteremia.

Kelesidis T, Humphries R, Ward K, Lewinski MA, Yang OO.

Diagn Microbiol Infect Dis. 2011 Nov;71(3):286-90. doi: 10.1016/j.diagmicrobio.2011.07.001. Epub 2011 Aug 19.

PMID:
21855248
8.

Successful treatment of meticillin-resistant Staphylococcus aureus bacteraemia in a neonate using daptomycin.

Hussain A, Kairamkonda V, Jenkins DR.

J Med Microbiol. 2011 Mar;60(Pt 3):381-3. doi: 10.1099/jmm.0.027235-0. Epub 2010 Dec 2.

PMID:
21127158
9.

Daptomycin-resistant, methicillin-resistant Staphylococcus aureus bacteremia.

Mangili A, Bica I, Snydman DR, Hamer DH.

Clin Infect Dis. 2005 Apr 1;40(7):1058-60. Epub 2005 Feb 17.

PMID:
15825002
10.

Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.

Marty FM, Yeh WW, Wennersten CB, Venkataraman L, Albano E, Alyea EP, Gold HS, Baden LR, Pillai SK.

J Clin Microbiol. 2006 Feb;44(2):595-7.

11.

Bacteremia and infective endocarditis caused by a non-daptomycin-susceptible, vancomycin-intermediate, and methicillin-resistant Staphylococcus aureus strain in Taiwan.

Huang YT, Hsiao CH, Liao CH, Lee CW, Hsueh PR.

J Clin Microbiol. 2008 Mar;46(3):1132-6. doi: 10.1128/JCM.01844-07. Epub 2008 Jan 16.

12.

Daptomycin therapy failure in an adolescent with methicillin-resistant Staphylococcus aureus bacteremia.

Jacobson LM, Milstone AM, Zenilman J, Carroll KC, Arav-Boger R.

Pediatr Infect Dis J. 2009 May;28(5):445-7. doi: 10.1097/INF.0b013e3181927891.

PMID:
19295462
13.
14.

Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.

Fowler VG Jr, Boucher HW, Corey GR, Abrutyn E, Karchmer AW, Rupp ME, Levine DP, Chambers HF, Tally FP, Vigliani GA, Cabell CH, Link AS, DeMeyer I, Filler SG, Zervos M, Cook P, Parsonnet J, Bernstein JM, Price CS, Forrest GN, Fätkenheuer G, Gareca M, Rehm SJ, Brodt HR, Tice A, Cosgrove SE; S. aureus Endocarditis and Bacteremia Study Group..

N Engl J Med. 2006 Aug 17;355(7):653-65.

15.

Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin.

Sakoulas G, Rose W, Rybak MJ, Pillai S, Alder J, Moellering RC Jr, Eliopoulos GM.

J Clin Microbiol. 2008 Jan;46(1):220-4. Epub 2007 Nov 14.

16.

Staphylococcus aureus meningitis: case series and literature review.

Aguilar J, Urday-Cornejo V, Donabedian S, Perri M, Tibbetts R, Zervos M.

Medicine (Baltimore). 2010 Mar;89(2):117-25. doi: 10.1097/MD.0b013e3181d5453d. Review.

17.

Daptomycin for eradication of a systemic infection with a methicillin-resistant-Staphylococcus aureus in a biventricular assist device recipient.

Weis F, Beiras-Fernandez A, Kaczmarek I, Sodian R, Vicol C, Reichart B, Weis M.

Ann Thorac Surg. 2007 Jul;84(1):269-70.

PMID:
17588430
18.

The treatment triangle for staphylococcal infections.

Grayson ML.

N Engl J Med. 2006 Aug 17;355(7):724-7. No abstract available.

PMID:
16914709
19.
20.

Diminished vancomycin and daptomycin susceptibility during prolonged bacteremia with methicillin-resistant Staphylococcus aureus.

Bennett JW, Murray CK, Holmes RL, Patterson JE, Jorgensen JH.

Diagn Microbiol Infect Dis. 2008 Apr;60(4):437-40. Epub 2007 Dec 21.

PMID:
18096352

Supplemental Content

Support Center